bebtelovimab

01/01/2023 - "We systematically searched five electronic databases (PubMed, CENTRAL, Embase, Global Health, and PsycINFO) from date of inception to September 30, 2022, for studies reporting on the effect of bebtelovimab in SARS-CoV-2 infection, using a combination of search terms around -bebtelovimab‖, -LY-CoV1404‖, -LY3853113‖, and -coronavirus infection‖. "
07/01/2023 - "Among 22,720 patients with SARS-COV-2 infection, 3739 bebtelovimab-treated patients were matched to 5423 untreated patients. "
07/01/2023 - "Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5."
04/01/2023 - "Bebtelovimab was given post-transplant day 1 because the recipient remained seronegative to COVID-19. "
01/01/2023 - "Preclinical evidence suggests bebtelovimab be a potential treatment for COVID-19 amidst viral evolution. "

10/01/2022 - "Among bebtelovimab-treated patients, the most common comorbidities were hypertension (42.7%), diabetes (17.1%), and an immunosuppressed condition (17.0%). "
11/26/2022 - "Four monoclonal antibody products (casirivimab + imdevimab, bamlanivimab, bamlanivimab + etesevimab, and bebtelovimab) were associated with higher reporting of hypertension. "

08/01/2022 - "Bebtelovimab is a monoclonal antibody used to prevent progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. "

08/01/2022 - "Bebtelovimab-Induced Bradycardia Leading to Cardiac Arrest."
08/01/2022 - "We describe the case of an 86-year-old male infected with SARS-CoV-2 who experienced bradycardia with cardiac arrest immediately following infusion of Bebtelovimab with return of spontaneous circulation obtained following 1 minute of chest compressions and administration of atropine. "

08/01/2022 - "His bradycardia resolved, and he was extubated on hospital day 1, found to be neurologically intact, and discharged on hospital day 9. Due to the time course of the patient's symptomatology, we attribute the bradycardic arrest to the Bebtelovimab infusion. "
08/01/2022 - "Bebtelovimab-Induced Bradycardia Leading to Cardiac Arrest."
08/01/2022 - "We describe the case of an 86-year-old male infected with SARS-CoV-2 who experienced bradycardia with cardiac arrest immediately following infusion of Bebtelovimab with return of spontaneous circulation obtained following 1 minute of chest compressions and administration of atropine. "